✦ LIBER ✦

Association of chromosome 10 losses and negative prognosis in oligoastrocytomas

✍ Scribed by Lorena Bissola; Marica Eoli; Bianca Pollo; Bianca Maria Merciai; Antonio Silvani; Ettore Salsano; Carmelo Maccagnano; Maria Grazia Bruzzone; Anna Maria Fuhrman Conti; Carlo Lazzaro Solero; Sergio Giombini; Giovanni Broggi; Amerigo Boiardi; Gaetano Finocchiaro

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 165 KB
Volume: 52
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.10405

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Loss of heterozygosity at 10q in tumors

Loss of heterozygosity at 10q in tumors of the upper respiratory tract is associated with poor prognosis

✍ Daniela Gasparotto; Tamara Vukosavljevic; Sara Piccinin; Luigi Barzan; Sandro Su 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 114 KB 👁 2 views

Frequent loss of a specific chromosomic region in cancers is often associated with inactivation of a tumor-suppressor gene. The long arm of chromosome 10 is deleted in several types of tumor, among them squamous-cell carcinomas of the head and neck (HNSCC). To determine the role of 10q deletions in

Loss of STARD10 expression identifies a

Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status

✍ Niamh C. Murphy; Andrew V. Biankin; Ewan K.A. Millar; Catriona M. McNeil; Sandra 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 368 KB

## Abstract The phospholipid transfer protein STARD10 cooperates with __c‐erbB__ signaling and is overexpressed in __Neu/ErbB2__ breast cancers. We investigated if STARD10 expression provides additional prognostic information to HER2/__neu__ status in primary breast cancer. A published gene express

Allelic losses at loci on chromosome 10

Allelic losses at loci on chromosome 10 are associated with metastasis and progression of human prostate cancer

✍ Akira Komiya; Hiroyoshi Suzuki; Takeshi Ueda; Ryuichi Yatani; Mitsuru Emi; Haruo 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 733 KB

DNA samples from tumors and paired normal tissues from 48 patients with prostate cancer (stage B, I 6 cases; stage C, I 4 cases; stage D, I 8 cases) were examined with 26 polymorphic markers spanning chromosome 10. Allelic losses were observed in I7 of the 46 cases (37%) that were informative with a

Loss of heterozygosity on chromosomes 10

Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma

✍ Ittmann, Michael M. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 665 KB

Loss of heterozygosity (LOH) at chromosomal loci has been associated with the presence of tumor suppressor genes at the deleted loci. Twenty-six clinically localized, Stage B prostate carcinomas were analyzed for LOH on chromosomes 10 and 17 using microsatellite markers. Two of 26 carcinomas showed

Loss of 11q and 16q in Wilms tumors is a

Loss of 11q and 16q in Wilms tumors is associated with anaplasia, tumor recurrence, and poor prognosis

✍ Stefanie Wittmann; Birgit Zirn; Muhannad Alkassar; Peter Ambros; Norbert Graf; M 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB 👁 2 views

## Abstract Allele loss of chromosome arms 11q and 16q in Wilms tumors has been associated with different clinical parameters in prior studies. To substantiate these findings in a large collection of tumors treated according to the GPOH/SIOP protocol and to narrow down critical regions, we performe

Chromosomal losses of regions on 5q and

Chromosomal losses of regions on 5q and lack of high-level amplifications at 8q24 are associated with favorable prognosis for ovarian serous carcinoma

✍ Annette Staebler; Bianca Karberg; Juliane Behm; Petra Kuhlmann; Ulrike Neubert; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB

## Abstract In this study, we describe characteristic chromosomal alterations in a consecutive series of 96 serous ovarian tumors by comparative genomic hybridization. We analyze their association with different pathways of progression, histological grade, and clinical outcome. The most striking di